RoslinCT is a cell therapy contract development and manufacturing organisation based at Edinburgh BioQuarter. It works with biotechnology and pharmaceutical companies developing advanced cell-based therapies, supporting programmes from process development through to regulated manufacturing.
The business grew from scientific expertise linked to the Roslin Institute and was founded as a spin-out in 2006. Its Edinburgh operation includes licensed GMP manufacturing facilities designed for clinical and commercial cell-therapy production, with capabilities for autologous and allogeneic therapies and gene-editing workflows. RoslinCT now operates across both Edinburgh and the United States, giving customers access to a transatlantic development and manufacturing network.
Roslin Cell Therapies Limited is registered in Scotland under SC512315 and trades as RoslinCT. Its Scottish headquarters at 9 Little France Road sits within Edinburgh BioQuarter. The company is relevant to life-sciences businesses seeking specialist process development, technology transfer and advanced-therapy manufacturing capacity in Scotland.